Recipharm AB will publish its interim report for the third quarter 2020 on 5th November at 07:45 am CET.

The company invites investors, analysts and media to a web conference (in English) on 5th November at 10:00 am CET, where CEO Thomas Eldered and CFO Tobias Hagglov will present and comment on the report as well as answer questions. The presentation can be followed live, or afterwards on www.recipharm.com/investor-relations.

The report will be available on www.recipharm.com/investor-relations from 7:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 5th November.

Click here to participate in the web conference.

Questions may be submitted by dialling below telephone numbers during the conference. If you don't wish to ask questions by telephone you only need to participate through the link above.

From Sweden: +46 8 566 426 51

From France: + 33 170 750 711

From Germany: +49 691 380 34 30

From India: +91 227 127 96 10

From Israel: +972 372 076 79

From Italy: +39 023 601 38 21

From Portugal: +351 210 609 105

From Spain: +34 935 472 900

From the UK: +44 333 300 08 04

From the USA: +1 631 913 14 22

Pin code for participants: 67679708#

Contact:

Tel: +46 8 602 52 00

Email: ir@recipharm.com

(C) 2020 Electronic News Publishing, source ENP Newswire